Lasa Supergenerics has been granted patents for its key products for the period of 20 years. The company has been granted patents for ‘An improved process for the preparation of Methyl 5-(Propylthio)-1h-Benzo [D] Imidazol-2-Ylcarbanate’ and ‘Process for the preparation of Benzimidazole Derivative as Anthelmintic Agents.’ Till date the company has been successfully granted 6 patents and rest 2 are in pipeline.
Lasa Supergenerics, pioneer and amongst the leading players in the manufacturing of APIs in India through its catalyst chemistry expertise and fully backward integrated unit.
